glp-1 without diabetes Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Optimizing GLP-1 therapies for obesity

Insurance coverage for anti-obesity medications varies [58], leading to inconsistent access across different populations

This necessity makes long-term financial planning critical for treatment success

Most treatment discontinuations were due to gastrointestinal AE and occurred during the rapid escalation phase this may be mitigated with more gradual dose escalation at phase 3 trials

Contrave Safety and Side Effects Common side effects of Contrave include dry mouth, changes in taste, nausea, vomiting, diarrhea, constipation, dizziness, headache, fatigue, flushing, sweating, uncontrolled shaking, and ringing in the ears